DKSH and FrontierView Publish Whitepaper on Southeast Asia as a Growth Accelerator for Global Healthcare Firms
World Council of Optometry and Alcon Launch “WCO Alcon Dry Eye Wheel” Tool in Spanish
CORE Publication on Multifocal Contact Lenses Builds Fitting Confidence and Aids Wearer Adoption
Expert Panel Discusses How to Reduce Contact Lens Dropout
IMC 2024 News: Multiple Studies Reinforce SightGlass Vision DOT Efficacy for Myopia Management
CLI Research Pinpoints Actions to Reduce Contact Lens Dropout
Myopia Action Month Returns, Uniting ECPs Worldwide this September
CLI Teams with Football Broadcaster Gene Steratore for Healthy Contact Lens Wear
New CORE Publication Provides Guidance on Cosmetics and Ocular Health
Myopia Profile Launches 'Made Simple' Courses to Empower ECPs with Practical Myopia Management
-
CooperVision Leads Myopia Control Dialogue: Bridging Optometry and Ophthalmology
CooperVision's leadership in advancing myopia control and establishing it as the standard of care in ocular health was prominently featured at the recent World Congress of Paediatric Ophthalmology and Strabismus (WCPOS V) in Kuala Lumpur, Malaysia. Continuing this momentum, CooperVision will also be showcased at the upcoming World Ophthalmology Congress (WOC) in Vancouver, Canada. These engagements underscore the company’s commitment to fostering collaboration between ophthalmology and optometry professionals worldwide. “Ophthalmology and the optometry communities are equally pivotal in driving adoption and standards of care, uncovering critical insights, and shaping the future of myopia control and management—endeavors we are honored to support and enhance,” said Elizabeth Lumb, BSc (Hons) MCOptom, FIACLE, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “Leveraging both communities is crucial for developing a unified approach to myopia management, which can lead to reaching more patients with aligned treatment approaches.” During WCPOS V, CooperVision hosted the 2024 APAC Luminary Event, successfully bridging ophthalmology and optometry through an active roundtable discussion aimed at creating an industry white paper. Eye care professionals (ECPs) from both professions contributed insights to the forthcoming publication, "Joint Consensus on Standardizing Clinical Use of Contact Lenses for Myopia Management Across Ophthalmology and Optometry." In addition, CooperVision engaged both professions by presenting the results of its MiSight® 1 day seven-year clinical study. Professor Nicola Logan, Principal Investigator of the MiSight® 1 day clinical trial at Aston University, shared these insights along with findings from a separate investigator-initiated study at the company’s sponsored lunch symposium. Additionally, five scientific posters provided further evidence-based perspectives and practical strategies for managing myopia progression in children. Later this summer, CooperVision will sponsor the International Medical Contact Lens Council (IMCLC) Symposium to be held at WOC on August 16. The event, “Innovation in Contact Lens Use,” will convene global ophthalmology experts to discuss CooperVision’s advancements in myopia control. It will also underscore IMCLC’s dedication to worldwide education and information dissemination on contact lens-related topics for providers. “Our involvement in these conferences demonstrates CooperVision's unwavering commitment to the ophthalmology community and highlights our dedication to advancing the understanding and management of childhood myopia through evidence-based strategies,” said Lumb. “By spotlighting groundbreaking advancements in myopia control, CooperVision is facilitating meaningful dialogue and driving collective action within both fields, addressing the urgent need for a coordinated strategy to tackle the growing challenge of myopia.” For more information on these two events, visit wcposv2024.org and icowoc.org
-
Second Annual Myopia Action Month Set for September 2024
Following a successful inaugural year, Myopia Profile today announced the return of Myopia Action Month in September 2024. This global event is poised to deliver 30 days of tailored education, industry collaboration, and encouragement to empower eye care professionals (ECPs) to more effectively address the disease, helping counter growing prevalence rates. The global initiative aligns with the World Council of Optometry’s advocacy for myopia patient care and is fully supported by Myopia Profile’s visionary sponsors. “When we launched Myopia Action Month last year, feedback from the eye care community and industry was essential in shaping the curriculum,” said Dr. Kate Gifford, co-founder of Myopia Profile. “Heading into the second year, we’re expanding upon a successful foundation. The 2024 edition will bring even more engaging content and practical learning experiences.” This year’s program features two educational tracks, “Foundations” and “Advanced,” each offering an on-demand package of four 15-minute recorded lectures covering a variety of topics. Sponsor product videos will accompany Myopia Profile’s science-based lectures to support practical understanding. Additionally, expanded social media activities will encourage ECPs to post, share, and discuss Myopia Action Month, while new and existing resources will further support ECPs in refining their myopia management strategies. “The resources we’re developing are designed to empower ECPs at any stage to refine their myopia action plans and management strategies,” said Dr. Gifford. “Our 2024 event will introduce new practice support, online courses, downloadable resources, and a host of other additions. We had a fantastic first year, and we’re committed to making this September even more valuable in turning myopia knowledge and awareness into action.” More information about Myopia Action Month, including how to register at no cost, will be published on myopiaprofile.com in the coming months.
-
Latest CORE Publication Offers Soft Toric Contact Lens Insights for Practitioners
Prescribing soft toric contact lenses is center stage for Issue 78 of Contact Lens Update. Left uncorrected when eye care providers instead prescribe spherical soft lenses, astigmatism can lead to reduced visual acuity, visual fatigue, poor overall vision quality, and dropout. Published by the Centre for Ocular Research & Education (CORE), the bi-monthly publication is available at no charge by visiting ContactLensUpdate.com “The benefits of prescribing toric soft contact lenses for low to moderate astigmatism are important to consider, given that 45% of our patients have 0.75 D or more of refractive astigmatism, and 35% have 1.00 D or more,” said Daddi Fadel, DOptom, FSLS, FBCLA, FAAO, FIACLE, a clinical scientist at CORE. “The inability to tolerate the visual disturbances caused by residual astigmatism is a major reason why many patients abandon soft contact lenses. Recognizing the advantages and surmounting obstacles like visual performance, comfort, cost, and chair time are essential for patients' well-being. When assessing the cost-effectiveness of soft toric lenses compared to spherical ones in astigmatic individuals, practitioners should note that toric lenses provide significant advantages, often surpassing wearers' expectations despite the increased cost. Prescribing toric soft contact lenses for low and moderate astigmatism should become a standard practice.” Philip Morgan is professor of Optometry, head of Optometry, deputy head of the Division of Pharmacy and Optometry, and director of Eurolens Research at The University of Manchester. His editorial highlights evidence that indicates some patients who could benefit from toric soft contact lenses are not receiving appropriate fitting. Additionally, his piece debunks conceived barriers such as poor visual performance, reduced comfort, and increased cost and chair time. Dr. Melissa Barnett is the director of Optometry at the University of California, Davis, and globally recognized expert in specialty and scleral lenses, dry eye disease, keratoconus, and presbyopia. She authors the feature article examining the willingness to pay for soft toric lenses versus spherical contact lenses in individuals with astigmatism, shedding light on consumers' perceived value of the attributes of these lenses. Doerte Luensmann, a senior clinical scientist at the Centre for Ocular Research and Education, is involved in clinical trial management for multisite studies conducted in Canada and worldwide to support the development of study designs and management of clinical sites. Her clinical insight presents a case report illustrating the ineffectiveness of spherical lenses in correcting corneal astigmatism, emphasizing the significance of prescribing toric soft contact lenses for even low levels of astigmatism. The conference highlight is shared by Micheal Read, the new technologies manager at Eurolens Research, The University of Manchester, where he liaises with the contact lens industry and manages clinical and laboratory research projects. His poster presents the findings of their study on the visual effectiveness of soft toric contact lenses in cases of mild to moderate astigmatism. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
Avalue to Showcase Cutting-edge Smart Healthcare Solutions at Japan's International Modern Hospital Show 2024
Avalue Technology Inc. (TAIEX: 3479-TW), a global leader in industrial computer solutions, will participate in the International Modern Hospital Show (IMHS) in Tokyo, Japan, from July 10 to 12, 2024. Avalue will showcase a range of innovative solutions designed for smart healthcare, emphasizing our commitment to streamlining healthcare workflows and providing smarter solutions that drive the future of the healthcare industry. At this exhibition, Avalue will present the following highlight products: l Patient Information Solutions with Over-bed Vitals Sensor: The Over-bed Vitals Sensor, integrated into the SmartCaring T60, improves patient care in hospitals and long-term care facilities. Offering contactless monitoring, this solution ensures safety by utilizing millimeter wave and thermal sensors to track vital signs, including breathing, heart rate, temperature, and activity. l High-Performance Computing and Motherboards for High-End Medical Devices: Designed to meet the compute-intensive demands of industrial workloads, Avalue's HPC solutions enable organizations to harness the potential of artificial intelligence for data analytics, machine learning, and process optimization. l Real-Time Location System (RTLS) Solution: This advanced RTLS solution offers unparalleled insight into operations with its advanced RTLS capabilities, enabling real-time tracking of assets and personnel with indoor positioning accuracy within 30 centimeters. l Bedside Infotainment System: Enhance the patient experience and provide them with access to a range of entertainment options and useful information during their hospital stay. l ePaper Signs and Note Pad: Eco-friendly and easy-to-update digital paper solutions includes 25” digital signage and 10" HannsNote 2 Pad for ePaper signs and handheld note pad. These solutions are designed to keep patients informed and involved in their healthcare journey, prioritizing communication throughout the care process. l Medical Panel PC: Experience the pinnacle of medical computing with our Intel Processor Medical Panel PCs. Engineered for healthcare, our Medical Panel PCs boast advanced features, including front IP65 medical displays, ensuring optimal performance and reliability. l Telehealth System: Provides efficient and convenient telemedicine services, enabling patients to receive professional medical care at home or remote area. l Accelerated Osteoporosis Screening Solution: This AI solution uses advanced deep learning technology and digital X-ray flat-panel sensors to quickly assess osteoporosis risk, delivering recommendations within just 6 seconds. This provides a cost-effective, time-efficient, and highly accurate approach for bone density assessment. Avalue looks forward to meeting with attendees at IMHS 24. To explore these innovative smart hospital solutions, please visit Avalue and its partners at Booth #215. See you there. International Modern Hospital Show 2024 Information: l Date: 10-12 July, 2024 l Venue: Tokyo Big Sight, Tokyo, Japan l Booth No.: 215 l Show Information: https://www.noma-hs.com/
-
Overcoming Children’s Eye Health Obstacles @ IAPB’s 2030 In Sight Live
The next several weeks are packed with events and announcements, plus we are headed into summer holidays in the Northern Hemisphere. With so much happening, I wanted to make sure that one gathering did not go unnoticed. CooperVision’s Stuart Cockerill, a myopia management pioneer and leader of the company’s myopia management lifecycle team, will be part of a blue ribbon panel exploring how to prioritize children’s eye care on national and global agendas. Scheduled for Thursday, June 27, at 3:15 pm CST, 2030 In Sight for our Children is part of the International Agency for the Prevention of Blindness 2030 In Sight Live conference, taking place in Mexico City and virtually via livestream. Joining Stuart will be representatives from the India Vision Institute, the Fred Hollows Foundation, Queens University Belfast, Renovatio, the Global Partnership for Assistive Technology, and IAPB. You can read more about the conference, view the entire program, and register at https://www.iapb.org/learn/our-events/2030-in-sight-live-mexico/
-
World Council of Optometry and Alcon Extend Global Partnership for Dry Eye Disease Education
The World Council of Optometry (WCO) and Alcon are extending their education initiative to advance global, evidence-based dry eye disease education, which has garnered widespread exposure and interest over the past two years. Dry eye disease is a chronic, painful condition that impacts 1.4 billion people worldwide,[1] with reports of increased occurrence aligning with notable factors such as increasing use of technology, environmental triggers, and an aging population.[2] As part of the renewed collaboration, an update to the existing WCO Alcon Dry Eye Wheel is now available. This practical tool is designed to raise optometrists’ understanding of dry eye disease diagnosis and practical management. Now expanded to include content surrounding diet / dietary supplements, in-office and complex treatments, the latest version provides multifaceted, evidence-based knowledge that can be used in nearly all eye care environments. A dedicated website at dryeye.worldcouncilofoptometry.info includes a series of dry eye webinars recorded with world-renowned opinion leaders and also provides a robust collection of resources that can be used in clinical and educational settings. WCO President Sandra Block, O.D., M. Ed., MPH, FAAO, FCOV, said, “Extending our partnership with Alcon supports the education of optometrists globally about practical measures to better address dry eye, a condition that, without proper diagnosis and treatment, can lead to ocular surface disease. This year, we are planning more collaboration with university educators to increase access to the WCO Alcon Dry Eye Wheel and related educational resources for future generations of eye care professionals.” “We are all becoming more aware of the growing incidence and impact of dry eye on our patients. Within the last year, we have seen publications further clarifying some of the issues contributing to this rise¾from digital device use to social and environmental factors,” said Carla Mack, OD, MBA, FAAO, FBCLA, Head, Global and U.S. Professional Education and Development for Alcon. “We are proud to extend our ongoing partnership with the World Council of Optometry, reinforcing our commitment to helping make dry eye more understandable for both eye care professionals and patients. The ultimate goal is to empower optometrists to engage in conversations about this multi-factorial condition and educate on management options for their patients experiencing dry eye symptoms.” More information on the updated version of the WCO Alcon Dry Eye Wheel and other activities planned for the second year of the partnership will be posted to www.worldcouncilofoptometry.info and to the initiative’s dedicated website at dryeye.worldcouncilofoptometry.info ### [1] MarketScope (2020) 2020 Dry Eye Products Market Report. A Global Analysis for 2019 to 2025. October 2020. [2] Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K et al. (2017) TFOS DEWS II Epidemiology Report. Ocul Surf 15 (3): 334-365.
-
SightGlass Vision DOT Data Affirms Myopia Management Performance
Myopia management innovator SightGlass Vision will present new data surrounding its Diffusion Optics Technology™ (DOT 0.2) spectacle lenses from four studies at the ARVO 2024 Annual Meeting, which will draw thousands of eye and vision scientists to Seattle from May 5-9. The collective scientific body of knowledge deepens support for DOT™ spectacle lenses’ efficacy, safety, mechanism of action, and positive patient experience. The company’s flagship myopia control intervention uses thousands of light scattering elements to mimic more natural contrast on the retina—a unique mechanism of action to slow myopia progression in children. Building on its long-term CYPRESS trial, SightGlass Vision initiated CATHAY—a two-year, randomized, controlled clinical trial of children ages 6 to 13 across five sites in China. Control of Myopia Using Diffusion Optics Technology (DOT) Spectacle Lenses in a Chinese Population (Laughton D, et al) analyzes 71 participants at the six-month mark, indicating that DOT lenses substantially slowed myopia progression, as measured by cycloplegic spherical equivalent refraction (cSER) and axial length (AL), compared to the standard single vision spectacle lens control group. AL increased from baseline by 0.19 mm (p <0.001) in the control compared to -0.05 mm (p=0.04) among DOT lens wearers. cSER increased from baseline by -0.38D (p<0.0001) among the control versus by 0.01D (p=0.85) with the DOT group. Unadjusted mean differences in the changes from baseline were significant: -0.23 mm for AL and 0.39D for cSER. “The CATHAY interim results further validate the findings from our multi-year CYPRESS study, supporting the hypothesis that modulating retinal contrast can slow myopia progression in children from diverse populations,” said Debbie Laughton, BSc, PhD, Director of Medical Affairs for SightGlass Vision. Short Term Effect of DOT Spectacle Lenses on Choroidal Thickness in Emmetropic Children (Jabeen A, et al) illustrates the macula choroidal thickening (ChT) in children following short-term DOT spectacle lens wear, similar or greater to response from +3.00D spectacle lens use—a positive indication that contrast reduction favorably affects this uveal tract tissue. Conducted by the Centre for Ocular Research & Education (CORE), the research enrolled 30 children ages 8 to 14 in a two-visit, prospective, randomized, subject-masked crossover study. Treatment Zone Visual Acuity with Myopia Control Spectacle Lenses (Rani R, et al) profiles the immediate effect of Diffusion Optics Technology (DOT), Defocus Incorporated Multiple Segments (DIMS), and Highly Aspherical Lenslets (HAL) interventions on high- and low-contrast foveal visual acuity (VA). Investigators from Aston University’s Optometry & Vision Science Research Group enrolled 20 myopia adults in the prospective, single-visit, double-blind, four-way randomized crossover study to compare the technologies to single vision plano spectacle lenses. All three myopia management technologies performed well against the single vision lens, with DOT lenses providing superior VA in the peripheral treatment zone. Aston researchers are also presenting findings from The Short-Term Effects of Spectacle-Based Myopia Management Interventions on Dynamic Vision (Davis L, et al), which used the same group of participants. Dynamic vision when wearing DOT, DIMS, or HAL spectacle lenses was noted as good and generally similar to the single vision control. “Our scientific program at ARVO 2024 adds to the substantial evidence supporting the myopia control efficacy of Diffusion Optics Technology, as well as guiding eye care professionals on making more informed choices regarding spectacle lens interventions. We are enthusiastic about how DOT lenses have been received in multiple countries and remain excited by the prospect of reaching even more children around the world,” said Andrew Sedgwick, CEO of SightGlass Vision. SightGlass Vision’s patent-protected technology with clinically proven efficacy[1],[2],[3],[4] has made its commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. The company operates as a joint venture of CooperCompanies and EssilorLuxottica. For more information, visit SightGlassVision.com ### [1] Chalberg T., et al. Control of Myopia Using Diffusion Optics Spectacle Lenses: Efficacy and Safety Study (CYPRESS) 42-month results. ARVO 2023 Annual Meeting presentation. 27 April 2023. [2] Control of myopia using Diffusion Optics Technology™ spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). British Journal of Ophthalmology Published Online First: 01 September 2022. DOI: 10.1136/bjo-2021-321005 [3] Rappon J., et al. Two-year effectiveness of a novel myopia management spectacle lens with full-time WEARERS. Invest. Ophthalmol. Vis. Sci. 2022;63(7):408. [4] Laughton, D et al. Safety and Efficacy of a Novel Spectacle Lens for Myopia Control Over Three Years. 2022 American Academy of Optometry annual meeting. 27 Oct 2022.
-
CLI Report Highlights Ways to Attract Potential & Former Contact Lens Patients
The Contact Lens Institute (CLI) has published an in-depth report on everyday actions that the eye care community can take to draw interest from potential and former contact lens wearers. Based on research with more than 1,000 vision-corrected adults segmented by glasses-only wearers, new contact lens wearers, and contact lens dropouts, “Beyond Vision: Behaviors to Attract New & Returning Contact Lens Wearers” is the latest offering from CLI’s See Tomorrow initiative, which helps practices thrive using exclusive consumer data and insights. The 26-page document includes multiple infographics depicting high value takeaways, which are ideal for staff training. Another 19 quick take columns and bulleted checklists offer practical implementation tips, all of which were contributed by 2024 CLI Visionaries. The report is available for download or online reading at https://www.contactlensinstitute.org/resources/see-tomorrow/. “With 47.8% of glasses wearers indicating a high interest in trying contact lenses, and lapsed contact lens wearers signaling what would motivate them to resume use, the tremendous untapped potential for the category is unmistakable,” said Stan Rogaski, CLI’s executive director. “Our research found specific areas of consumer excitement, concern, and misperception that eye care practices can leverage to aid more efficient and effective contact lens conversations among likely candidates. Better yet, these aspects can be reinforced easily and quickly across the entire patient experience, from appointment scheduling to the exam to follow-up, by every member of the practice team.” Highlights explored within the “Beyond Vision” report include: Sources of contact lens influence, led by optometrists and ophthalmologists (66% of glasses wearers / 46% of new contact lens wearers), opticians (44% of glasses wearers / 26% of new contact lens wearers), and friends and family (40% of glasses wearers, 31% of new contact lens wearers). A ranking of 25 factors that would aid potential wearers’ consideration of contacts, with an eye doctor explaining why contacts can benefit a patient placing first (66%). Other aspects that practice teams may take for granted were also evident, such as understanding insertion and removal (52%), taking trial lenses home (51%), and knowing about the range of price and performance options (47%). Primary motivators for initial contact lens trial among new wearers, who called out freedom from glasses (44%), personal appearance (42%), and ease of use (39%) as the most significant. A review of which contact lens advancements spark the most excitement, with toric designs (46%) and UV protection (43%) cited most by potential wearers, and contacts for digital device use and UV protection tied for the highest spot (64%) by new contact lens wearers. Practice behaviors that detract from contact lens trial, including a lack of exam staff raising the subject, not alerting patients they were candidates, and not providing contact lens information—all cited by about 20% of glasses-only respondents. Additional non-behavioral issues that dissuade trial, including fear factors such as patients not wanting to touch their eye (44%) and infection concerns (25%); affordability (30%); and misperceptions that having dry eye (27%) and astigmatism (17%) prevent contact lens wear—most of which can be addressed through communication. Ratings from former contact lens wearers of what would motivate them to return, split by those who dropped out within the past two years compared to longer-term dropouts. Among more recent dropouts, awareness of new advances (55%), a renewed conversation with their eye doctor about contact lens benefits (50%), dual/part-time wear alongside glasses (50%), and the availability of trial lenses (50%) were at the top. Those who abandoned wear longer ago placed the most weight on being made aware of contact lenses for a specific eye condition (85%), of new advances and technologies (74%), price and performance options (72%) and access to trial lenses (66%). The additive value of having contact lens advocates throughout the practice, as up to 30% of glasses-only wearers reported that such enthusiasm would influence their decision to try contacts. When it comes to discussing the benefits of contact lenses, the research outcomes emphasized the importance of doctors personally having that conversation, versus fully delegating information sharing to their teams. For glasses wearers, the recommendation from the optometrist or ophthalmologist matters to 66% of them, compared to 22% for eye exam staff and 8% for eyewear display staff. 2024 CLI Visionaries who contributed to “Beyond Vision” are Monica Bhula, OD; Shelby Brogdon, OD; Andrew S. Bruce, LDO, ABOM, NCLEM, FCLSA; Jenn Seymour Brusven, LDO, NCLE-AC, ABO-AC, AAS; Ariel Cerenzie, OD, FAAO, FSLS; Angelica Cifuentes, OD; Jade Coats, OD; Jason Compton, OD, FAAO; Janelle Davison, OD; Sabrina Gaan, OD; Lisa Hornick, OD, MBA, FAAO; Diana Mejia; Scott Moscow, OD; Ashley O’Dwyer, OD; Shalu Pal, OD, FAAO, FSLS, FBCLA, FIAOMC; Adam Ramsey, OD; Noha Seif, OD, FAAO, FSLS; Dana Shannon, OD, FAAO; and Jennifer Tsai, OD. The research was commissioned by the Contact Lens Institute and conducted by Prodege from February 1-9, 2024, via an online survey. Respondents included 1,053 vision-corrected adults ages 18-64 residing in the United States. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators
The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) today announced a collaboration to provide university-level instructors with direct access to CLI-developed research publications and practice tools. Nearly 950 IACLE members—spanning more than 600 academic institutions and 81 countries—will be able to view and download CLI training and professional development materials from IACLETOP, the organization’s digital resource and teaching platform. These include multilingual assets for The EASY Way, CLI’s program to promote healthy contact lens wear-and-care, and in-depth consumer and practice management reports from CLI’s See Tomorrow initiative. “Putting Contact Lens Institute materials in the hands of contact lens educators around the globe allows them to be even more closely connected to relevant trends and insights from top clinicians. This will translate into better preparing tens of thousands of students entering the profession, who in turn can deliver better patient care and improved practice performance,” said Bonnie Boshart, chief executive officer of IACLE. Established in 1979, IACLE welcomes contact lens educators from all eye care professions and related disciplines. The non-profit organization is dedicated to raising the standard of contact lens education and promoting the safe use of contact lenses worldwide. It is the leading provider of educational and information resources essential to contact lens educators. For more information, visit iacle.org The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
CORE Publication Helps ECPs Prepare for New Wave of Dry Eye Disease Medications
In response to accelerating clinical interest about new, innovative treatments for dry eye disease, the Centre for Ocular Research & Education (CORE) has dedicated Issue 77 of Contact Lens Update to several recent introductions and promising pipeline developments. The publication is available at no charge by visiting ContactLensUpdate.com. “Dry eye disease affects millions of people across the world and can have a significant impact on their lives. Our growing understanding of this complex condition has led to the development of multiple new medications—both approved for sale and undergoing trials—that we believe have important clinical potential,” said Alex Hui, Head of Biosciences at CORE. “In primary eye care settings, dry eye is encountered daily. These additional treatments, targeting different aspects of the disease, will offer practitioners more options to incorporate into their prescribing arsenal and help patients better manage the condition.” Hui, who is also an adjunct associate professor at the School of Optometry and Vision Science, UNSW Sydney, shares his expertise in the issue’s editorial. His overview covers recently approved treatments such as a short-term corticosteroid to treat acute periods of worsened dry eye, a preservative-free ophthalmic solution that slows tear evaporation, and investigational products that either target inflammation or stimulate receptors on the ocular surface to increase the production of tears. The feature article is authored by Etty Bitton, a professor and director of the Externship Program and Dry Eye Clinic, School of Optometry, University of Montreal. She summarizes the findings of a systematic review and meta-analysis that investigated the efficacy and safety of a novel nasal spray to manage dry eye. Her article provides an overview of how different doses can impact signs of dry eye and reviews observed ocular and non-ocular adverse events. Quillan M. Austria, an ophthalmology resident at Weill Cornell Medical Center, New York Presbyterian Hospital, and Christopher Starr, an associate professor of ophthalmology and director of ophthalmic education at Weill Cornell Medical Center, co-author the issue’s clinical insight column. The case report details a patient’s experience with dry eye and management with a recently approved ophthalmic solution to treat Demodex blepharitis. The conference highlight is contributed by Alison Ng, a Lead Clinical Scientist at CORE, University of Waterloo. The abstract summarizes a presentation from the American Academy of Optometry 2023 annual meeting, detailing a phase two clinical trial that investigated the use of a new topical ointment to treat meibomian gland dysfunction. The work details changes in signs and symptoms over a three-month period of use. Published six times per year, Contact Lens Update provides a global platform for unbiased clinical insights based in current research. Since 2011, each issue has provided dependable and up-to-date ocular health information for more than 60,000 leading eye care professionals. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
Insights from Myopia Profile: Record Engagement & Impact Worldwide
Myopia Profile, the globally recognized clinical myopia management information center for eye care professionals (ECPs), today announced significant growth of traffic and engagement on its website, www.myopiaprofile.com. The 50% year-over-year increases signal widespread and accelerating interest in myopia etiology, prevention, interventions, and clinical practices. Innovative features and expanded functionalities were added to the site last year to offer more comprehensive product and scientific information. The subsequent surge in usage reflects continued interest in ECP demand for myopia resources and educational materials for their practices, further advancing the myopia management category and positive patient outcomes. “Revamping our website was a significant undertaking, and the payoff has been truly rewarding as we reviewed the year-end results,” said Dr. Kate Gifford, co-founder of Myopia Profile. “With over 200 countries seeking information on diverse topics in myopia and children’s vision care, it’s evident that there’s huge appetite for high quality and effective content. We’re delighted to offer invaluable and ever-expanding resources, aiding in the fight against the escalating myopia epidemic.” The top six countries accessing Myopia Profile’s free content were the United States, India, the United Kingdom, Australia, Canada, and Singapore, respectively. Users explored a diverse range of topics, encompassing axial length, myopia control spectacle lenses, contact lenses, and atropine; clinical techniques for children, and adult myopia management. Notably, the site’s new search feature and world-first Myopia Control Product Compendium revealed significant interest in spectacle lenses such as Stellest® and MiYOSMART, as well as for MiSight® 1 day myopia control contact lenses. Searches related to atropine also demonstrated substantial growth. In addition, Myopia Profile observed significant growth on www.mykidsvision.org, its consumer-facing website dedicated to providing parents with accessible, evidence-based information on myopia and its management at no cost. The platform aims to enhance awareness and education, with visitors soaring following extensive upgrades completed about 18 months ago. Here, orthokeratology and atropine emerged as the top-performing and fastest-growing search terms. Additionally, there has been a rise in searches regarding axial length and screen time, suggesting a transfer of prevention and care information from ECPs to caregivers. The three most popular topics were screen time, atropine eye drops, and spectacles. “We consistently engage with users to ensure we deliver the most relevant information tailored to their needs and practices,” said Dr. Gifford. “By listening to their feedback, in combination with keeping our eyes on the latest research, we can update our site with the most current information available. This ongoing process is rewarding because we understand that we are delivering precisely what ECPs need to assist their patients effectively.” To find out more about Myopia Profile and My Kids Vision, visit www.myopiaprofile.com and www.mykidsvision.org
-
EyeDocs of Rock Become the “Good Habits” in Support of New Contact Lens Institute Research
For more than 30 years, tens of thousands of music lovers from across the eye care and eyewear world have turned out to hear the Bad Habits—“The EyeDocs of Rock”—play in venues large and small. When the band kicked off its second set at the 2024 Vision Expo East opening event in New York, fans packing Sony Hall at the Paramount Hotel had to look twice: the group had suddenly rebranded itself as the Good Habits for one night only. This temporary name change resulted from a partnership with the Contact Lens Institute™ (CLI). The industry association is previewing new consumer research that shows how simple adjustments to how eye care practices communicate with patients can spark increased contact lens prescribing—bad habits made good. “As practicing optometrists, we couldn’t resist the chance to have some fun with this new CLI data, helping bring awareness to some intriguing insights that can benefit both patients and practices alike,” said bassist Michael “Jules” Raies, OD. Among the CLI findings were that significant untapped contact lens demand exists, with almost one in two (47.8%) U.S. glasses wearers who have never tried contacts saying they are highly interested. However, only one in 10 (10.5%) said their optometrist or ophthalmologist had recommended they consider contact lenses, with even lower rates from exam staff (6%), optical/eyewear display staff (3%), and administrative staff (2%) within the office. Adorned in jet black t-shirts with a custom Good Habits logo, the band launched into a song apropos for the moment: Lipps Inc.’s Funkytown and its signature “talk about it, talk about it, talk about it, talk about it” lyrics. As hundreds sang and danced along, the animated Good Habits logo twirled across the walls, encouraging everyone to visit GoodHabitsRock.com. The "Good Habits" at Sony Hall: keyboardist Dr. Bob Glass , guitarist Dr. Pat Dollenmayer, drummer Dr. Tony Fenton, bassist Dr. Michael “Jules” Raies, and keyboardist/guitarist Mark Schindler. CLI expects to publish its in-depth research report in April, part of its See Tomorrow initiative. Copies can obtained at no cost by visiting GoodHabitsRock.com or ContactLensInstitute.org The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org.
-
Research Shows Communications Adjustments Could Boost Contact Lens Adoption
Simple adjustments to how eye care practices communicate with patients may attract a significantly higher number of contact lens wearers, according to new data from the Contact Lens Institute (CLI). The industry association is previewing its latest See Tomorrow initiative consumer research at Vision Expo East this week, ahead of publishing an in-depth report next month. The findings reveal significant untapped contact lens demand, with almost one in two (47.8%) glasses wearers who have never tried contacts saying they are highly interested. However, only one in 10 (10.5%) said their optometrist or ophthalmologist had recommended they consider contact lenses, with even lower rates for exam staff (6%), optical/eyewear display staff (3%), and administrative staff (2%) within the office. “Our research has consistently shown that vision-corrected adults are waiting for their doctors to raise the possibility of contact lens wear—a straightforward action that enhances patient satisfaction and practice success,” said Stan Rogaski, CLI’s executive director. “This latest work delved even deeper into how that and other behaviors by practice teams play enormous roles in attracting or dissuading consumers from contemplating contact lenses and their many benefits.” More than half (51%) of glasses wearers said their lack of contact lens trial was directly influenced by in-practice behaviors or lack thereof. Specific detractors included not having been asked about contact lenses (20%), not being told they were a candidate (19%), and not being provided with contact lens information (18%). The same respondents were also asked to weigh 25 factors that would influence their consideration of contact lenses—all actions largely within the control of offices. Having their eye doctor explain why contact lenses would benefit the patient ranked first (66%), followed by understanding how to insert and remove lenses (52%), being given trial lenses at their appointment (51%), having a wide range of price and performance options (47%), and being aware of contacts for specific eye conditions (46%). While underlining that the entire practice team should communicate the advantages of contact lens wear, the CLI research highlighted that the optometrist or ophthalmologist must not completely delegate that responsibility. The influence of the aforementioned doctor’s recommendation (66%) is markedly more influential among patients than recommendations from exam staff (22%) and from eyewear display staff (8%). - Vision Expo East Events During Vision Expo East’s opening night event on Friday, March 15, CLI and the Bad Habits—the “EyeDocs of Rock”—will strike a unique musical partnership to bring added visibility to the latest research. Show attendees can present their badge for admission at Sony Hall at the Paramount Hotel Times Square, beginning at 9 p.m. ET. On Saturday, March 16, at 11 a.m. ET, several CLI Visionaries—eye care professionals who exemplify outstanding contact lens prescribing practices—will discuss the preliminary research findings on the Vision Expo East “The Bridge” main stage, sharing how they work with their teams to instill and reinforce behaviors that attract new contact lens wearers. “Beyond Vision: Behaviors to Supercharge Your Contact Lens Business” panelists include Jason Compton, OD, FAAO, Sabrina Gaan, OD, Scott Moscow, OD, and Adam Ramsey, OD, with moderation from Andrew Bruce, LDO, ABOM, NCLEM, FCLSA. “Opportunities to grow contact lens prescribing, with all the positives that brings to patient and practice, are substantial and well within reach of eye care offices. The Contact Lens Institute is excited to put this information into the hands of the eye care community, and offer ideas and insights for easy implementation,” said Rogaski. The research was commissioned by the Contact Lens Institute and conducted by Prodege from February 1-9, 2024, via an online survey. Respondents included 1,053 vision-corrected adults ages 18-64 residing in the United States. The sample size for glasses wearers who had never tried contact lenses was 579. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
Avalue Technology to Showcase Cutting-Edge Healthcare Solutions at HIMSS 2024
Avalue Technology will showcase its latest advancements in healthcare solutions at the upcoming HIMSS Global Health Conference & Exhibition, taking place at the McCormick Place Convention Center in Orlando, FL from March 12-14, 2024. Collaborating with its partners, Avalue will highlight innovative technologies tailored for smart hospitals, with a focuse on: l Embedded Motherboard for Medical Devices l 3D Displays Medical Panel PC / Open Frames l High Performance Computing for Medical Imaging l Medical Mobile Workstation Laptop Carts l Patient Information Solutions Over-bed Vitals Sensor l ePaper Patient Signs l LCD Patient Signs l Telehealth System To learn more about Avalue's offerings, please visit: https://www.avalue.com/public/HIMSS24/ At HIMSS24, Avalue will demonstrate its commitment to streamlining healthcare workflows and providing smarter solutions. One of the key showcases will be the VI-SOR Smart Operating Room Dashboard Solution, in partnership with AUO Display Plus. This innovative solution, paired with the Avalue MAB-T600, enables visualization for streamlined workflows with a unified data dashboard, surgical lists and records, real-time video streaming, and plug-and-play integration. In addition, the 3D imaging solution for remote surgical training features a 32-inch 4K 3D medical display capable of streaming 3D images for robotic and minimally invasive surgeries. The Over-bed Vitals Sensor, integrated into the SmartCaring T60 improves patient care in hospitals and long-term care facilities. Offering contactless monitoring, this solution ensures safety by utilizing millimeter wave and thermal sensors to track vital signs including breathing, heart rate, temperature, and activity. With Azure Sphere and cloud technology, personalized care delivery is enabled, prioritizing patient comfort and privacy while reducing infection risks and aiding in early detection of deterioration without burdening staff. Avalue's smart ward solution includes ePaper displays for 42” communication boards and 25” digital signage, patient infotainment, and ePaper/LCD patient signs. These solutions are designed to keep patients informed and involved in their healthcare journey, prioritizing communication throughout the care process. Another area of focus is the telehealth system, with Avalue offering powerful portable batteries medical cart to ensure uninterrupted medical care, along with AVer medical-grade PTZ cameras with AI functions designed for patient monitoring. The Medical Mobile Workstation Laptop Carts, designed to fit most laptops/notebooks, provide ample space and easy usability. Avalue looks forward to meeting with attendees at HIMSS24. To explore these innovative smart hospital solutions, please visit Avalue and its partners at booth #4681. For more information on Avalue solutions and the HIMSS24 showcase, please visit Avalue's website at https://www.avalue.com/en or contact our sales team at sales@avalue-usa.com
-
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update. Published by the Centre for Ocular Research & Education (CORE), the bi-monthly publication is available at no charge by visiting ContactLensUpdate.com. “Specialty lenses play a vital role in addressing diverse visual needs and managing myopia. Keeping abreast of the latest research is essential for evidence-based practice, ensuring that patients receive optimal care aligned with current understanding,” said Daddi Fadel, DOptom, FSLS, FBCLA, FAAO, FIACLE, a clinical scientist at CORE and author of the issue’s opening editorial. “By integrating insights from different fields and staying informed about emerging techniques and technologies, practitioners can achieve successful lens fittings that address immediate concerns and contribute to long-term ocular health preservation. Interdisciplinary collaboration further enhances the effectiveness of treatment plans, allowing for a comprehensive approach that considers various aspects of ocular health and—paramount to provide customized care that meets each patient's unique needs.” Dr. Fadel is a pioneer of modern lens designs, editor-in-chief of the Journal of Contact Lens Research & Science, and author of several peer-reviewed articles and books. Her editorial presents comprehensive highlights from the 2024 Global Specialty Lens Symposium (GSLS). These include discussions on the inflammatory nature of contact lens wear, the Ed Bennett-Nathan Efron debate concerning the viability of rigid lenses, masterclasses and workshops on scleral lenses and myopia management, and emerging technologies presentations. Sharon Qiu is a residency-trained optometrist pursuing a full-time Ph.D. in Vision Science at CORE while also serving as a part-time clinical supervisor for 4th-year optometry interns at the University of Waterloo Contact Lens and Myopia Control Clinic. She authors the feature article that explores techniques for practitioners to evaluate the performance of scleral lenses, and the instruments that are most suitable for this purpose. Greg DeNaeyer, an optometrist at Arena Eye Surgeons in Delaware, Ohio, with an emphasis on specialty contact lenses and a contributor to several professional publications, shares his expertise in the form of a clinical insight. The article reviews three of the most common scleral lens fitting complications—poor wettability, midday fogging, and corneal edema—and suggests methods to enhance the process and performance, such as using modern materials, coatings, and alternative treatments. The conference highlight is shared by David Hammond, a researcher specializing in myopia control at CooperVision's Advanced Development Center in Pleasanton, Calif. His award-winning poster examined MiSight 1 day's effectiveness in controlling myopia progression over six years, comparing progression between control and treatment cohorts, including a group whose treatment was initiated in year four. The study found that MiSight 1 day effectively controlled myopia progression, especially benefiting faster-progressing eyes, with consistent proportional treatment effects that contradict predictions of a random growth model. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by the International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
Contact Lens Institute Reboots "EASY Does It" Video Series
Several prominent members of the U.S. and Canadian eye care community are voicing their support for The EASY Way, the Contact Lens Institute’s (CLI) initiative to help promote healthy, comfortable contact lens wear and care behaviors. CLI has rebooted its popular “EASY Does It” one-minute video series, in which optometrists, opticians, and staff describe one way their colleagues can better reach patients through conversations that take only seconds. 2024 CLI Visionaries including Monica Bhula, OD, Jenn Seymour Brusven, LDO, Janelle Davison, OD, Scott Moscow, OD, Shalu Pal, OD, and Adam Ramsey, OD, are featured in new episodes, with additional segments planned throughout the coming weeks. All “EASY Does It” videos are available as a YouTube playlist at bit.ly/EASYDoesIt. Now in its fourth year, The EASY Way (Eyes, Awareness, Safety and You) has been adopted by eye care practices across the U.S., Canada, and worldwide. It includes simplified tips, attention-grabbing infographics, and companion digital resources for use in practices, presented in a memorable and straightforward way. All components are available for free download within The EASY Way resource page on ContactLensInstitute.org. At the center of the program are three easy steps: 1. Think Clean. Wash and dry your hands every time before touching your lenses or eyes. If you wear reusable lenses, always clean and disinfect them with each removal, and clean your lens case as directed. Keep your lenses and case away from any type of water, which can contain harmful microorganisms. 2. Remember Fresher is Better. Wear your contacts for only as long as your eye care professional says, replacing them with fresh lenses on schedule. Only wear daily disposable lenses once, and always rely on new solution for reusable lens disinfection and storage. Replace your lens case at least every three months. 3. Trust Your Eye Doctor. Listen to your eye care professional, who has specialized training. If you have any questions, contact their office—they care about your health and great vision. The rebooted “EASY Does It” video series is being promoted across CLI’s social media channels, CLI Visionaries’ personal and practice digital channels, and through CLI member companies Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
SightGlass Vision Receives FDA Breakthrough Device Designation
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses, which are intended to slow myopia progression in children. The unique design is the first to use the contrast management mechanism of action, incorporating thousands of elements that gently scatter light across the retina. The FDA’s Breakthrough Devices Program is for highly innovative devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions. Manufacturers are given more frequent opportunities for FDA feedback during the premarket review phase, as well as a prioritized submission review. Since the program’s introduction in 2015, only 18 other ophthalmic devices have received the Breakthrough Device designation.* “The FDA Breakthrough Device designation for Diffusion Optics Technology™ (DOT™) spectacle lenses is a milestone for our organization—and for the broader fight against the pediatric myopia epidemic. Recent studies1,2 illustrate that about half of U.S. children are myopic, yet most are not receiving treatments proven to slow myopia progression,” said Andrew Sedgwick, CEO of SightGlass Vision. “We are enthusiastic about more closely collaborating with the FDA as we pursue U.S. market clearance.” SightGlass Vision’s patent-protected technology has demonstrated proven efficacy and safety through rigorous clinical evaluation.3,4,5,6 As reported in September 2023, full four-year outcomes from the pivotal CYPRESS study showed statistically significant slowing of axial length progression and cycloplegic spherical equivalent refraction.7 Diffusion Optics Technology™ (DOT™) spectacle lenses have made their commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. For more information, visit SightGlassVision.com
